We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Depomed Says Teva Unit Infringed Diabetes Patents

Law360 (September 25, 2007, 12:00 AM EDT) -- Pharmaceutical company Depomed Inc. has asked a California court for summary judgment in a case accusing a Teva Pharmaceutical Industries Ltd. subsidiary of infringing two patents related to the diabetes drug metformin.

Depomed filed a corrected version of its motion for summary judgment on Tuesday, saying that Teva unit Ivax Corp. doesn't seem to be putting up a fight with respect to the infringement claims.

The basis for Menlo Park, Calif.-based Depomed's motion is what it characterizes as undisputed evidence that Ivax's Metformin ER contains every...
To view the full article, register now.